Abstract:Insufficient data on nano- and microplastics (NMP) hinder robust evaluation of their potential health risks. Methodological disparities and the absence of established toxicity thresholds impede comparability and practical application of research findings. The diverse attributes of NMP, such as variations in sizes, shapes, and compositions, complicate human health risk assessment. Although probability density functions (PDFs) show promise in capturing this diversity, their integration into risk assessment frameworks is limited. Physiologically based kinetic (PBK) models offer a potential solution to bridge external exposure and internal dosimetry for risk evaluation. However, the heterogeneity of NMP poses challenges for accurate biodistribution modeling. A literature review encompassed both experimental and modeling studies was conducted to examine biodistribution studies of monodisperse micro- and nanoparticles. The literature search in PubMed and Scopus databases yielded 39 studies that met the inclusion criteria. Evaluation criteria were adapted from previous Quality Assurance and Quality Control (QA-QC) studies, best practice guidelines from WHO (2010), OECD guidance (2021), and additional criteria introduced to address the context of NMP risk assessment. Subsequently, a conceptual framework for a comprehensive NMP-PBK model was developed, addressing the multidimensionality of NMP particles. Model parameters for an NMP-PBK model are presented. The QA-QC evaluations revealed that most experimental studies receive relatively good scores (>0) for particle characterizations and environmental settings but lacked in the application for biodistribution model criteria. Meanwhile, the evaluation of modeling studies revealed that information regarding the model type and allometric scaling requires improvement. Three potential applications of PDFs in PBK modeling of NMP are identified: capturing the multidimensionality of the NMP continuum, quantifying the probabilistic definition of external exposure, and calculating the bio-accessibility fraction of NMP in the human body. A framework for an NMP-PBK model is proposed, integrating PDFs for enhanced risk assessment of the impact of NMP on human health.

Integration of In Vitro and In Vivo Models to Predict Cellular and Tissue Dosimetry of Nanomaterials Using Physiologically Based Pharmacokinetic Modeling

Pluripotent Stem Cells: an in Vitro Model for Nanotoxicity Assessments

Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling of Nanomaterials

Bridging the gap: Innovative human-based in vitro approaches for nanomaterials hazard assessment and their role in safe and sustainable by design, risk assessment, and life cycle assessment

Application of physiologically based pharmacokinetic model in toxicology of nanomaterials:research advances

In vivo safety evaluation method for nanomaterials for cancer therapy

Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis Tools

Simulation of the In Vivo Fate of Polymeric Nanoparticles Traced by Environment-Responsive Near-Infrared Dye: A Physiologically Based Pharmacokinetic Modelling Approach

Nano- and Microplastic PBK modeling in the context of human exposure and risk assessment

An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice

Drug-loaded nanoparticles for cancer therapy: a high-throughput multicellular agent-based modeling study

A physiologically based toxicokinetic model for microplastics and nanoplastics in mice after oral exposure and its implications for human dietary exposure assessment

Novel Methods and Approaches for Safety Evaluation of Nanoparticle Formulations: A Focus Towards In Vitro Models and Adverse Outcome Pathways

The Effects of Physicochemical Properties of Nanomaterials on Their Cellular Uptake in Vitro and in Vivo

Bridging Smart Nanosystems with Clinically Relevant Models and Advanced Imaging for Precision Drug Delivery

Modelling and predicting the biological effects of nanomaterials

PBPK modeling and simulation in drug research and development

Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs)

In vitro nanoparticle dosimetry for adherent growing cell monolayers covering bottom and lateral walls

Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials

A novel In Vitro Model for Studying Nanoparticle Interactions with the Small Intestine